Declared Dividend • May 21
Dividend of HK$0.30 announced Shareholders will receive a dividend of HK$0.30. Ex-date: 9th June 2026 Payment date: 13th July 2026 Dividend yield will be 23%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (28% earnings payout ratio) and cash flows (21% cash payout ratio). The dividend has increased by an average of 13% per year over the past 9 years. However, payments have been volatile during that time. EPS is expected to grow by 67% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Board Change • May 21
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Zhizhong Ma was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. 공시 • Mar 05
Dongyue Group Limited to Report Fiscal Year 2025 Results on Mar 25, 2026 Dongyue Group Limited announced that they will report fiscal year 2025 results on Mar 25, 2026 공시 • Jan 02
Dongyue Group Limited Announces Nomination Committee Appointments, Effective 31 December 2025 The board of directors of Dongyue Group Limited announced that Ms. Chung Tak Lai (Ms. Chung), an executive Director, and Mr. Ma Zhizhong (Mr. Ma), an independent non-executive Director, have been appointed as members of the nomination committee of the Company with effect from 31 December 2025. Following the appointment of Ms. Chung and Mr. Ma, the Nomination Committee has one Director of a different gender, and still comprises a majority of independent non-executive Directors. The above change in composition of the Nomination Committee is implemented in response to the amended Corporate Governance Code as set forth in Appendix C1 to the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited (the ``Stock Exchange'') which is currently in effect. 공시 • Jul 25
Dongyue Group Limited to Report First Half, 2025 Results on Aug 26, 2025 Dongyue Group Limited announced that they will report first half, 2025 results on Aug 26, 2025 공시 • Jun 05
Dongyue Group Limited Approves Final Dividend for the Year Ended 31 December 2024 Dongyue Group Limited at the Annual General Meeting held on 5 June 2025, approved declared a final dividend of HKD 0.10 per Share for the year ended 31 December 2024. 공시 • Feb 24
Dongyue Group Limited to Report Fiscal Year 2024 Results on Mar 27, 2025 Dongyue Group Limited announced that they will report fiscal year 2024 results on Mar 27, 2025 Buy Or Sell Opportunity • Oct 25
Now 24% overvalued Over the last 90 days, the stock has fallen 1.9% to €0.77. The fair value is estimated to be €0.62, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 28% in 2 years. Earnings are forecast to grow by 183% in the next 2 years. Reported Earnings • Sep 29
First half 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.13 in 1H 2023) First half 2024 results: EPS: CN¥0.17 (up from CN¥0.13 in 1H 2023). Revenue: CN¥7.26b (flat on 1H 2023). Net income: CN¥307.6m (up 8.4% from 1H 2023). Profit margin: 4.2% (up from 3.9% in 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 26% per year, which means it is performing significantly worse than earnings. Buy Or Sell Opportunity • Sep 26
Now 28% overvalued Over the last 90 days, the stock has fallen 23% to €0.78. The fair value is estimated to be €0.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 44% in 2 years. Earnings are forecast to grow by 208% in the next 2 years. Reported Earnings • Aug 30
First half 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.13 in 1H 2023) First half 2024 results: EPS: CN¥0.17 (up from CN¥0.13 in 1H 2023). Revenue: CN¥7.26b (flat on 1H 2023). Net income: CN¥307.6m (up 8.4% from 1H 2023). Profit margin: 4.2% (up from 3.9% in 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 40% per year, which means it is performing significantly worse than earnings. 공시 • Aug 02
Dongyue Group Limited to Report First Half, 2024 Results on Aug 28, 2024 Dongyue Group Limited announced that they will report first half, 2024 results on Aug 28, 2024 공시 • Jun 08
Dongyue Group Limited Approves Final Dividend for the Year Ended 31 December 2023 Dongyue Group Limited at its annual general meeting held on June 6, 2024, approved a final dividend of HKD 0.10 per Share for the year ended 31 December 2023. Upcoming Dividend • Jun 04
Upcoming dividend of HK$0.10 per share Eligible shareholders must have bought the stock before 11 June 2024. Payment date: 12 July 2024. Payout ratio is a comfortable 28% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%). Valuation Update With 7 Day Price Move • May 09
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to €1.02, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 79% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €0.58 per share. Reported Earnings • May 02
Full year 2023 earnings released: EPS: CN¥0.32 (vs CN¥1.73 in FY 2022) Full year 2023 results: EPS: CN¥0.32 (down from CN¥1.73 in FY 2022). Revenue: CN¥14.5b (down 28% from FY 2022). Net income: CN¥707.8m (down 82% from FY 2022). Profit margin: 4.9% (down from 19% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Declared Dividend • Mar 29
Dividend of HK$0.10 announced Shareholders will receive a dividend of HK$0.10. Ex-date: 11th June 2024 Payment date: 12th July 2024 Dividend yield will be 12%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (28% earnings payout ratio) and cash flows (60% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 151% over the next 3 years, which should provide support to the dividend and adequate earnings cover. 공시 • Mar 27
Dongyue Group Limited, Annual General Meeting, Jun 06, 2024 Dongyue Group Limited, Annual General Meeting, Jun 06, 2024. New Risk • Mar 27
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 4.9% Last year net profit margin: 19% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (344% cash payout ratio). Share price has been volatile over the past 3 months (9.0% average weekly change). Profit margins are more than 30% lower than last year (4.9% net profit margin). Reported Earnings • Mar 27
Full year 2023 earnings released: EPS: CN¥0.32 (vs CN¥1.73 in FY 2022) Full year 2023 results: EPS: CN¥0.32 (down from CN¥1.73 in FY 2022). Revenue: CN¥14.5b (down 28% from FY 2022). Net income: CN¥707.8m (down 82% from FY 2022). Profit margin: 4.9% (down from 19% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. 공시 • Mar 02
Dongyue Group Limited to Report Fiscal Year 2023 Results on Mar 26, 2024 Dongyue Group Limited announced that they will report fiscal year 2023 results on Mar 26, 2024 New Risk • Feb 29
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 3.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 3.9% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (448% cash payout ratio). Share price has been volatile over the past 3 months (8.2% average weekly change). Large one-off items impacting financial results. Buy Or Sell Opportunity • Feb 21
Now 29% overvalued after recent price rise Over the last 90 days, the stock has risen 13% to €0.76. The fair value is estimated to be €0.59, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 46%. Revenue is forecast to decline by 3.4% in a year. Earnings are forecast to decline by 43% in the next year. Buy Or Sell Opportunity • Jan 19
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 2.4% to €0.65. The fair value is estimated to be €0.54, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 46%. Revenue is forecast to decline by 3.2% in a year. Earnings are forecast to decline by 43% in the next year. New Risk • Dec 21
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 17% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 17% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (448% cash payout ratio). Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results. Reported Earnings • Sep 17
First half 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.76 in 1H 2022) First half 2023 results: EPS: CN¥0.13 (down from CN¥0.76 in 1H 2022). Revenue: CN¥7.20b (down 29% from 1H 2022). Net income: CN¥283.9m (down 83% from 1H 2022). Profit margin: 3.9% (down from 17% in 1H 2022). Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. 공시 • Aug 08
Dongyue Group Limited to Report First Half, 2023 Results on Aug 25, 2023 Dongyue Group Limited announced that they will report first half, 2023 results on Aug 25, 2023 New Risk • Jun 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 7.9% per year for the foreseeable future. High level of non-cash earnings (22% accrual ratio). Minor Risks Dividend is not well covered by cash flows (97% cash payout ratio). Share price has been volatile over the past 3 months (7.3% average weekly change). 공시 • Jun 15
Dongyue Group Limited Provides Earnings Guidance for the Six Months Ending 30 June, 2023 Dongyue Group Limited provided earnings guidance for the six months ending 30 June, 2023. For the period, the Board expected that the Group may record a significant decrease in its net profit attributable to owners of the Company, as compared with that for the six months ended 30 June 2022. Upcoming Dividend • Jun 07
Upcoming dividend of HK$0.60 per share at 8.3% yield Eligible shareholders must have bought the stock before 14 June 2023. Payment date: 13 July 2023. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 8.3%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (5.8%). Reported Earnings • Mar 29
Full year 2022 earnings released: EPS: CN¥1.73 (vs CN¥0.98 in FY 2021) Full year 2022 results: EPS: CN¥1.73 (up from CN¥0.98 in FY 2021). Revenue: CN¥20.0b (up 26% from FY 2021). Net income: CN¥3.86b (up 86% from FY 2021). Profit margin: 19% (up from 13% in FY 2021). Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 48% per year whereas the company’s share price has increased by 43% per year. 공시 • Dec 15
Dongyue Group Limited Provides Consolidated Earnings Guidance for the Year Ending 31 December 2022 Dongyue Group Limited provided consolidated earnings guidance for the year ending 31 December 2022. The board expects that the Group may record a significant increase in its net profit attributable to owners of the company for the year ending 31 December 2022, as compared with that for the year ended 31 December 2021. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non-Executive Director Zhizhong Ma was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Nov 05
Investor sentiment improved over the past week After last week's 17% share price gain to €1.03, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 160% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €0.83 per share. Reported Earnings • Aug 23
First half 2022 earnings released: EPS: CN¥0.76 (vs CN¥0.29 in 1H 2021) First half 2022 results: EPS: CN¥0.76 (up from CN¥0.29 in 1H 2021). Revenue: CN¥10.1b (up 56% from 1H 2021). Net income: CN¥1.69b (up 181% from 1H 2021). Profit margin: 17% (up from 9.3% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to stay flat compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. 공시 • Jul 28
Dongyue Group Limited to Report First Half, 2022 Results on Aug 22, 2022 Dongyue Group Limited announced that they will report first half, 2022 results on Aug 22, 2022 공시 • Jun 22
Dongyue Group Limited Announces Demise of Zhang Bishu, Executive Director and Member of Corporate Governance Dongyue Group Limited announced that Mr. Zhang Bishu, an executive director and a member of the corporate governance of the company, passed away on 21 June 2022 due to illness. Mr. Zhang was appointed as the executive director and a member of the corporate governance committee of the company in May 2017. The Board will seek to appoint a new executive director of the Company as soon as possible. 공시 • Jun 15
Dongyue Group Limited Provides Earnings Guidance for the Six Months Ending June 30, 2021 Dongyue Group Limited provided earnings guidance for the six months ending June 30, 2021. For the period, the company announced that, based on the preliminary review of the unaudited consolidated management accounts of the Group for the five months ended 31 May 2022, the Group has recorded an increase by more than 170% in its net profit attributable to owners of the Company for the five months ended 31 May 2022, as compared with that for the corresponding period in 2021 and based on such information, the Board expects that the Group may record a significant increase in its net profit attributable to owners of the Company for the six months ending 30 June 2022, as compared with that for the six months ended 30 June 2021. Based on the information currently available, the Board considers that such increase was mainly attributable to therising market demand for the majority of the Group's products, new projects being put into operation with production and sales volume increased and the rapid growth brought by high-end products.The information contained in this announcement is only based on a preliminary assessment by the Board with reference to the unaudited consolidated management accounts of the Group for the fivemonths ended 31 May 2022 and information currently available to the Company, and is not based on any figures or information which have been reviewed by the Company's auditors. The interimfinancial reporting period for the Group ending 30 June 2022 has not yet ended and accordingly, the actual results of Group for such period may differ from the information contained in this announcement. Upcoming Dividend • Jun 07
Upcoming dividend of HK$0.34 per share Eligible shareholders must have bought the stock before 14 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 28% but the company is not cash flow positive. Trailing yield: 3.0%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (4.8%). Valuation Update With 7 Day Price Move • May 19
Investor sentiment improved over the past week After last week's 15% share price gain to €1.15, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 144% over the past three years. Reported Earnings • Apr 28
Full year 2021 earnings released: EPS: CN¥0.98 (vs CN¥0.38 in FY 2020) Full year 2021 results: EPS: CN¥0.98 (up from CN¥0.38 in FY 2020). Revenue: CN¥15.8b (up 58% from FY 2020). Net income: CN¥2.07b (up 169% from FY 2020). Profit margin: 13% (up from 7.7% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14%, compared to a 10% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Non-Executive Director Zhizhong Ma was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €1.05, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 72% over the past three years. 공시 • Mar 23
Dongyue Group Limited, Annual General Meeting, Jun 09, 2022 Dongyue Group Limited, Annual General Meeting, Jun 09, 2022. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improved over the past week After last week's 17% share price gain to €1.12, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 123% over the past three years. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment improved over the past week After last week's 16% share price gain to €1.14, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 120% over the past three years. 공시 • Feb 19
Dongyue Group Limited to Report Fiscal Year 2021 Results on Mar 21, 2022 Dongyue Group Limited announced that they will report fiscal year 2021 results on Mar 21, 2022 Valuation Update With 7 Day Price Move • Dec 02
Investor sentiment deteriorated over the past week After last week's 15% share price decline to €1.58, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 279% over the past three years. Valuation Update With 7 Day Price Move • Nov 06
Investor sentiment deteriorated over the past week After last week's 19% share price decline to €1.59, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 280% over the past three years. Recent Insider Transactions • Oct 16
CFO, VP & Executive Director recently bought €164k worth of stock On the 12th of October, Zhefeng Zhang bought around 100k shares on-market at roughly €1.64 per share. This was the largest purchase by an insider in the last 3 months. This was Zhefeng's only on-market trade for the last 12 months. Valuation Update With 7 Day Price Move • Oct 12
Investor sentiment deteriorated over the past week After last week's 27% share price decline to €1.60, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 269% over the past three years. Valuation Update With 7 Day Price Move • Sep 25
Investor sentiment deteriorated over the past week After last week's 21% share price decline to €2.08, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 343% over the past three years. 공시 • Sep 09
Dongyue Group Limited has completed a Follow-on Equity Offering in the amount of HKD 3.335 billion. Dongyue Group Limited has completed a Follow-on Equity Offering in the amount of HKD 3.335 billion.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 145,000,000
Price\Range: HKD 23
Transaction Features: Subsequent Direct Listing Reported Earnings • Sep 01
First half 2021 earnings released: EPS CN¥0.29 (vs CN¥0.20 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥6.47b (up 40% from 1H 2020). Net income: CN¥603.2m (up 49% from 1H 2020). Profit margin: 9.3% (up from 8.7% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has increased by 70% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improved over the past week After last week's 31% share price gain to €2.36, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 364% over the past three years. Valuation Update With 7 Day Price Move • Jul 30
Investor sentiment improved over the past week After last week's 24% share price gain to CN¥1.69, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 203% over the past three years. Recent Insider Transactions • Jul 09
Executive Director recently sold €399k worth of stock On the 7th of July, Jian Zhang sold around 397k shares on-market at roughly €1.00 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought €4.0m more than they sold in the last 12 months. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment improved over the past week After last week's 46% share price gain to CN¥1.07, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 17x in the Chemicals industry in Germany. Total returns to shareholders of 87% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €1.09 per share. 공시 • Jun 17
Dongyue Group Limited Provides Unaudited Consolidated Earnings Guidance for the Five Months Ended May 31, 2021 Dongyue Group Limited provided unaudited consolidated earnings guidance for the five months ended May 31, 2021. For the five months, the Group has recorded an increase by more than 50% in its net profit attributable to owners of the Company for the five months ended 31 May 2021, as compared with that for the corresponding period in 2020 and based on such information, the Board expects that the Group may record a significant increase in its net profit attributable to owners of the Company for the six months ending 30 June 2021, as compared with that for the six months ended 30 June 2020. Based on the information currently available, the Board considers that such increase was mainly attributable to the increase in demand for and market prices of the Group's products as a result of the recovery of China's economy and market sentiment due to the improvement in the novel coronavirus pandemic situation in 2021 as compared with 2020. Upcoming Dividend • Jun 08
Upcoming dividend of HK$0.14 per share Eligible shareholders must have bought the stock before 15 June 2021. Payment date: 16 July 2021. Trailing yield: 2.3%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%). Reported Earnings • Apr 17
Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.70 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥10.0b (down 23% from FY 2019). Net income: CN¥772.2m (down 47% from FY 2019). Profit margin: 7.7% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has remained flat, which means it is well ahead of earnings. 공시 • Mar 12
Dongyue Group Limited Announces Change of Executive Director and Independent Non-Executive Director Dongyue Group Limited announced that (i) Mr. Liu Chuanqi has resigned as executive Director and member of the Corporate Governance Committee; and (ii) Mr. Yue Rundong has resigned as independent non- executive Director and member of the Audit Committee and the Risk Management Committee, both with effect from 11 March 2021. The Board further announces that (i) Mr. Wang Weidong has been appointed as executive Director and member of the Corporate Governance Committee; and (ii) Mr. Ma Zhizhong has been appointed as independent non-executive Director and member of the Audit Committee and the Risk Management Committee, both with effect from 11 March 2021. Executive Departure • Mar 12
Independent Non Executive Director has left the company On the 11th of March, Rundong Yue's tenure as Independent Non Executive Director ended after 13.3 years in the role. We don't have any record of a personal shareholding under Rundong's name. A total of 2 executives have left over the last 12 months. Executive Departure • Mar 12
Executive Director has left the company On the 11th of March, Chuanqi Liu's tenure as Executive Director ended after 14.6 years in the role. We don't have any record of a personal shareholding under Chuanqi's name. A total of 2 executives have left over the last 12 months. Reported Earnings • Mar 10
Full year 2020 earnings released: EPS CN¥0.37 (vs CN¥0.70 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥10.0b (down 23% from FY 2019). Net income: CN¥772.2m (down 47% from FY 2019). Profit margin: 7.7% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. 공시 • Mar 10
Dongyue Group Limited, Annual General Meeting, Jun 10, 2021 Dongyue Group Limited, Annual General Meeting, Jun 10, 2021. Agenda: To consider the payment of a final dividend of HK$0.14 per share in respect of the year 2020. Is New 90 Day High Low • Feb 19
New 90-day high: €0.69 The company is up 55% from its price of €0.44 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. 공시 • Feb 17
Dongyue Group Limited to Report Fiscal Year 2020 Results on Mar 09, 2021 Dongyue Group Limited announced that they will report fiscal year 2020 results on Mar 09, 2021 공시 • Jan 29
Dongyue Group Limited Revised Financial Guidance for the Year Ended 31 December 2020 Dongyue Group Limited revised financial guidance for the year ended 31 December 2020. For the year, the company now expects, net profit attributable to shareholders of the company to be in the range of RMB 249,041,000 to RMB 332,055,000 against previous forecast of RMB 159,181,000 to RMB 174,960,000. Is New 90 Day High Low • Jan 26
New 90-day high: €0.68 The company is up 109% from its price of €0.33 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. Is New 90 Day High Low • Jan 07
New 90-day high: €0.65 The company is up 105% from its price of €0.31 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. Is New 90 Day High Low • Dec 19
New 90-day high: €0.51 The company is up 56% from its price of €0.32 on 18 September 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Nov 11
New 90-day high: €0.39 The company is up 6.0% from its price of €0.36 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 6.0% over the same period. Is New 90 Day High Low • Sep 26
New 90-day low: €0.30 The company is down 9.0% from its price of €0.33 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. Recent Insider Transactions • Sep 24
CEO & Chairman recently bought €4.4m worth of stock On the 17th of September, Jianhong Zhang bought around 19m shares on-market at roughly €0.24 per share. This was the largest purchase by an insider in the last 3 months. This was Jianhong's only on-market trade for the last 12 months. 공시 • Aug 06
Dongyue Group Limited to Report First Half, 2020 Results on Aug 27, 2020 Dongyue Group Limited announced that they will report first half, 2020 results on Aug 27, 2020 
